Related Experiment Video
Updated: Jun 20, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Patterns of youths' glycemic control with insulin pump therapy
Audrey Nelson1, Jennifer A Genthe, Kristin M Gall
1University of Nebraska Medical Center College of Nursing, Omaha, NE, USA.
Abstract:
Youths with type 1 diabetes mellitus may decide to use insulin pump therapy. Limited information describes youths' glycemic control with insulin pump therapy. A repeated-measures design guided data collection at five points from one month before insulin pump therapy through 12 months with insulin pump therapy. The research question was, "How do youths' hemoglobin A(1c) (HbA(1c)) values change with insulin pump therapy?" Glycemic control target was 7.6% HbA(1c) value. Thirty youths (9 to 18 years old) had at least 4 HbA(1c) values. Nineteen youths who achieved glycemic control had three different patterns during 12 months of insulin pump therapy. Eleven youths who did not achieve glycemic control had two different patterns. Multiple factors can influence a youth's glycemic control. Uncontrolled blood glucose levels increase the individual's risk for developing type 1 diabetes complications. Youths and health care providers need to work as a team to identify factors affecting the youth's glycemic control and discuss changes.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Type I Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
